WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ: NURO), a medical device company focused on the development and sale of proprietary products used to diagnose neuropathies, announced today that it is scheduled to present at the C.E. Unterberg, Towbin Life Sciences Conference at the New York Palace Hotel in New York City at 11:30am (EST) on Tuesday, October 31, 2006. The audio presentation will be simultaneously available via webcast on the “Investors” home page at http://www.neurometrix.com.
